ECU offers innovative and practical courses across a variety of disciplines and we have a vibrant research culture. ECU is a leader in developing alternative entry pathways to higher education.
We have three campuses in Western Australia. Joondalup and Mount Lawley in the Perth metropolitan area and our South West campus in Bunbury, 200km south of the Perth CBD.
ECU provides a variety of services and facilities that go beyond the classroom, with opportunities for personal development and social interaction for students and staff.
In Australia
International
At ECU we concentrate our research in areas of strength to deliver tangible outcomes.
There are several ways to get involved with research at ECU.
ECU has a lively research community that is committed to supporting research students.
Research Services provides comprehensive support services to researchers.
We value industry partnerships and offer access to world-class research across our nine ECU Strategic Research Institutes and Centres.
ECU links our stakeholders to our professional talent pool across a range of disciplines and research topics.
We collaborate with all types of businesses, including new start-ups, small to medium enterprises, not-for-profits, community organisations, government and large corporates in the resources sector.
ECU delivers training that can be tailored to industry needs.
Extra-curricular learning for childrenChildren's University Edith Cowan aims to inspire students between seven and fourteen to develop confidence and a love of learning through validated activities beyond the school curriculum.
The Inspiring Minds scholarship program are equity scholarships that give students an opportunity to access an education that may otherwise be out of reach.
EventsCatch up with fellow graduates at one of our regular alumni events.
We love to see our graduates back at ECU helping current students achieve their dreams.
Tell us what you've been up to since you graduated or stay in the alumni loop.
Take advantage of a range of career development or other alumni benefits.
Nikayla Batohi
Nikayla Batohi (PhD candidate)
Malignant melanoma is a highly aggressive cancer often resistant to treatment. Recent advances in immunotherapy, specifically immune checkpoint inhibitors (CPIs), have improved patient outcomes, but many challenges remain. B cells, which play critical roles in the tumour microenvironment, have shown promise as biomarkers for predicting CPI therapy outcomes. We aim to investigate the role of B cells in modulating responses to immune checkpoint inhibitors in advanced melanoma patients. The B cell repertoire will be characterised using multi-parametric flow cytometry and B receptor sequencing. Understanding how B cells influence responses to CPI therapy can lead to the development of reliable predictive biomarkers, differentiating responders from non-responders, thereby improving treatment outcomes in advanced melanoma.
Please leave a comment about your rating so we can better understand how we might improve the page.